Readystate Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$806K Buy
10,300
+2,500
+32% +$202K 0.03% 435
2026
Q1
$676K Buy
+7,800
New +$747K 0.03% 522
2025
Q2
Sell
-21,300
Closed -$1.91M 809
2025
Q1
$1.91M Buy
21,300
+700
+3% +$62.6K 0.06% 329
2024
Q4
$1.65M Sell
20,600
-183,500
-90% -$15.9M 0.05% 343
2024
Q3
$18.4M Buy
204,100
+195,000
+2,143% +$16.4M 0.34% 49
2024
Q2
$716K Sell
9,100
-167,300
-95% -$13.7M 0.02% 408
2024
Q1
$15.4M Buy
176,400
+175,100
+13,469% +$14.9M 0.22% 85
2023
Q4
$107K Buy
+1,300
New +$99.1K ﹤0.01% 584
2023
Q2
Sell
-4,000
Closed -$322K 360
2023
Q1
$322K Buy
+4,000
New +$326K 0.03% 209

Other funds holding MDT

Readystate Asset Management's MDT Position: Q2 2026 in Review

Readystate Asset Management increased its Medtronic (MDT) stake by 84% in Q2 2026, buying an estimated $201K and bringing the position to 5,451 shares worth $426K. The position accounts for 0.01% of the portfolio, ranked #698.

Readystate Asset Management first reported a position in MDT in Q1 2026 and has held it in 2 quarters since. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Readystate Asset Management held 5,451 shares of Medtronic worth $426K as of Q2 2026.
  • Readystate Asset Management bought 2,492 Medtronic shares in Q2 2026, an estimated $201K.
  • Medtronic made up 0.01% of Readystate Asset Management's portfolio in Q2 2026, its #698 holding.
  • Readystate Asset Management first reported a position in Medtronic in Q1 2026 and has held it in 2 quarters since.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Readystate Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.